Australian regulator promises significant cut in drug evaluation times
This article was originally published in SRA
Executive Summary
Plans by the Australian Therapeutic Goods Administration to cut evaluation times for prescription drug dossiers by a year have been welcomed by Medicines Australia, the national pharmaceutical industry association1,2.